AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12849771 — intervention group
Group type: EXPERIMENTAL
Intervention: IOR procedure combined with a Stroop task
Number of subjects: 4
Study 12849771 — intervention group
Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 4
Study 10099859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory withdrawal therapy
Number of subjects: 101
Study 10099859 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary withdrawal therapy
Number of subjects: 101
Study 10099859 — intervention group
Group type: COMPARATOR
Intervention: Total relapse rate
Number of subjects: 101
Study 8911442 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 annual doses of ivermectin
Number of subjects: 77
Study 8911442 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 6‐monthly doses of ivermectin
Number of subjects: 77
Study 8911442 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 77
Study 1648597 — intervention group
Group type: EXPERIMENTAL
Intervention: vindesine and cisplatin (VP)
Number of subjects: 199
Study 1648597 — intervention group
Group type: EXPERIMENTAL
Intervention: mitomycin, vindesine, and cisplatin (MVP)
Number of subjects: 199
Study 1648597 — intervention group
Group type: EXPERIMENTAL
Intervention: etoposide and cisplatin alternating with vindesine and mitomycin (EP/VM)
Number of subjects: 199
Study 6137895 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate analgesics (omnopon, pethidine, pentazocine)
Number of subjects: 37
Study 6137895 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (opiate/opioid antagonist)
Number of subjects: 37
Study 31576424 — intervention group
Group type: EXPERIMENTAL
Intervention: GRASP + tRNS
Number of subjects: 18
Study 31576424 — intervention group
Group type: COMPARATOR
Intervention: GRASP + Sham stimulation
Number of subjects: 18
Study 29954648 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy eating and physical-activity-focused behavioral intervention
Number of subjects: 10
Study 24250305 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training in addition to diet regimen
Number of subjects: 100
Study 24250305 — intervention group
Group type: COMPARATOR
Intervention: No treatment intervention
Number of subjects: 100
Study 20740477 — intervention group
Group type: EXPERIMENTAL
Intervention: HandTutor™ combined with traditional therapy
Number of subjects: 31
Study 20740477 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 31
Study 19965759 — intervention group
Group type: EXPERIMENTAL
Intervention: Relevance intervention (encouraged students to connect course materials to their lives)
Number of subjects: 0
Study 19965759 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 16835602 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet C (increased consumption of cereals)
Number of subjects: 67
Study 16835602 — intervention group
Group type: COMPARATOR
Intervention: Diet V (increased consumption of vegetables)
Number of subjects: 67
Study 15136304 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin sodium (low-molecular-weight heparin)
Number of subjects: 1102
Study 15136304 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1102
Study 11517856 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg/three times a day for 15 days)
Number of subjects: 19
Study 11517856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 9691893 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 96
Study 7560252 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloperidone 3 mg
Number of subjects: 0
Study 7560252 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloperidone 5 mg
Number of subjects: 0
Study 7560252 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloperidone with food
Number of subjects: 0
Study 7560252 — intervention group
Group type: COMPARATOR
Intervention: Control (fasted subjects)
Number of subjects: 0
Study 2225261 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied Norfloxacin 0.3%, 5 drops between 7.55 A.M. to 8 A.M. and after each hour until surgery.
Number of subjects: 0
Study 2225261 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied Norfloxacin 0.3%, 1 drop each quarter from 7 A.M. until surgery.
Number of subjects: 0
Study 2225261 — intervention group
Group type: COMPARATOR
Intervention: Comparison between the two groups (5 drops vs 1 drop each quarter).
Number of subjects: 0
Study 837172 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g or 200 g of liquorice daily for one to four weeks
Number of subjects: 14
Study 30777001 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil taken daily for 6 weeks
Number of subjects: 26
Study 25497383 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone follow-up with a semiquantitative urine pregnancy test and symptom checklist
Number of subjects: 2400
Study 25497383 — intervention group
Group type: COMPARATOR
Intervention: In-clinic follow-up
Number of subjects: 2400
Study 23444345 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniospinal radiotherapy (23.4 Gy) plus adjuvant chemotherapy
Number of subjects: 110
Study 22064991 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine 2 mg
Number of subjects: 10
Study 22064991 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine 4 mg
Number of subjects: 10
Study 22064991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 22064991 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg and 4 mg)
Number of subjects: 10
Study 19059750 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive elastic stockings (ES)
Number of subjects: 130
Study 19059750 — intervention group
Group type: COMPARATOR
Intervention: Conventional elastic stockings (ES)
Number of subjects: 130
Study 17033444 — intervention group
Group type: EXPERIMENTAL
Intervention: EASIE simulator training (group B)
Number of subjects: 35
Study 17033444 — intervention group
Group type: COMPARATOR
Intervention: Clinical education only (group A)
Number of subjects: 35
Study 12775404 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mini Mental State Exam (3MS)
Number of subjects: 7480
Study 10668837 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 3706
Study 10668837 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (CCBs)
Number of subjects: 3706
Study 10668837 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 3706
Study 10668837 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting nifedipine
Number of subjects: 3706
Study 10668837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release nifedipine
Number of subjects: 3706
Study 10668837 — intervention group
Group type: COMPARATOR
Intervention: Nonusers of antihypertensive drugs
Number of subjects: 3706
Study 7490809 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for stress urinary incontinence
Number of subjects: 57
Study 7490809 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for detrusor instability
Number of subjects: 57
Study 7490809 — intervention group
Group type: COMPARATOR
Intervention: Kegel exercise for stress urinary incontinence
Number of subjects: 57
Study 7490809 — intervention group
Group type: COMPARATOR
Intervention: Anticholinergic therapy for detrusor instability
Number of subjects: 57
Study 1593852 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple treatment (low-dose cyclosporine, azathioprine, methylprednisolone)
Number of subjects: 128
Study 1593852 — intervention group
Group type: COMPARATOR
Intervention: Combinations of two immunosuppressive drugs
Number of subjects: 128
Study 6739393 — intervention group
Group type: EXPERIMENTAL
Intervention: General support garments (roller bandage with shaped tubigrip - SBB - Seton and Sigvaris stockings)
Number of subjects: 98
Study 6739393 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-embolism supports (roller bandage plus pressure garment - Seton)
Number of subjects: 98
Study 30795785 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day crocin (2 plus crocin tablet, 15 mg BID)
Number of subjects: 50
Study 30795785 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 tablets per day, 15 mg BID)
Number of subjects: 50
Study 29228255 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-year community-wide intervention (CWI) using social marketing to promote physical activity (PA)
Number of subjects: 4414
Study 29228255 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-year community-wide intervention (CWI)
Number of subjects: 4414
Study 29228255 — intervention group
Group type: COMPARATOR
Intervention: Bundled approach promoting all forms of PA simultaneously
Number of subjects: 4414
Study 29228255 — intervention group
Group type: EXPERIMENTAL
Intervention: CWI awareness
Number of subjects: 4414
Study 29228255 — intervention group
Group type: COMPARATOR
Intervention: Intervention and control groups
Number of subjects: 4414
Study 26497264 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid coverage
Number of subjects: 10643
Study 26497264 — intervention group
Group type: COMPARATOR
Intervention: Not assigned to apply for Medicaid (Control)
Number of subjects: 10643
Study 24356073 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led hypertension clinic (n = 144)
Number of subjects: 353
Study 24356073 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 169)
Number of subjects: 353
Study 22207268 — intervention group
Group type: EXPERIMENTAL
Intervention: Perflubutane-based ultrasound
Number of subjects: 202
Study 22207268 — intervention group
Group type: COMPARATOR
Intervention: FIB4
Number of subjects: 202
Study 19856040 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg isobaric mepivacaine 1.5% plus 10 microg fentanyl (M + F group)
Number of subjects: 34
Study 19856040 — intervention group
Group type: COMPARATOR
Intervention: 45 mg isobaric mepivacaine 1.5% (M group)
Number of subjects: 34
Study 17643363 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dialysate calcium (LCD) 1.25 mmol/l
Number of subjects: 52
Study 17643363 — intervention group
Group type: COMPARATOR
Intervention: High calcium dialysate (HCD) 1.75 mmol/l
Number of subjects: 52
Study 16008972 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical UPPP (cUPPP)
Number of subjects: 68
Study 16008972 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified UPPP (mUPPP)
Number of subjects: 68
Study 16008972 — intervention group
Group type: COMPARATOR
Intervention: CPAP treatment
Number of subjects: 68
Study 16008972 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP therapy
Number of subjects: 68
Study 12221159 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (usually 400 mg/d)
Number of subjects: 24
Study 12221159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9791817 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ablation zone of 5.5 mm
Number of subjects: 60
Study 9791817 — intervention group
Group type: COMPARATOR
Intervention: Ablation zone of 5.5 mm with a transition zone of 1.0 mm
Number of subjects: 60
Study 8554732 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute losartan therapy (50 mg single dose)
Number of subjects: 11
Study 8554732 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic losartan therapy (42 days)
Number of subjects: 11
Study 2088623 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyl glove
Number of subjects: 29
Study 2088623 — intervention group
Group type: COMPARATOR
Intervention: Latex glove
Number of subjects: 29
Study 122333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1g daily for 4 weeks
Number of subjects: 27
Study 122333 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets of identical appearance for 4 weeks
Number of subjects: 27
Study 31951932 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined barley flour bread
Number of subjects: 23
Study 31951932 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat flour bread
Number of subjects: 23
Study 31127837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group acupuncture (once weekly for 12 weeks)
Number of subjects: 40
Study 31127837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group acupuncture (twice weekly for 12 weeks)
Number of subjects: 40
Study 31127837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group acupuncture (once or twice weekly for 12 weeks)
Number of subjects: 40
Study 31127837 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 28103704 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 61
Study 28103704 — intervention group
Group type: COMPARATOR
Intervention: Health education control (HEC)
Number of subjects: 61
Study 28103704 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling and nicotine patches
Number of subjects: 61
Study 25482435 — intervention group
Group type: EXPERIMENTAL
Intervention: Home administration of 200mg mifepristone
Number of subjects: 200
Study 25482435 — intervention group
Group type: COMPARATOR
Intervention: Clinic administration of 200mg mifepristone
Number of subjects: 200
Study 23370794 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 0
Study 23370794 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine pretreatment
Number of subjects: 0
Study 23370794 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone pretreatment
Number of subjects: 0
Study 23370794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20638864 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BiVP) optimization
Number of subjects: 22
Study 18951599 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating cathodic antigen (CCA) urine reagent strip
Number of subjects: 265
Study 18951599 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel treatment
Number of subjects: 265
Study 18951599 — intervention group
Group type: COMPARATOR
Intervention: Egg detection
Number of subjects: 265
Study 17298705 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic bread
Number of subjects: 38
Study 17298705 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-aox-bread
Number of subjects: 38
Study 17298705 — intervention group
Group type: COMPARATOR
Intervention: Control bread (placebo)
Number of subjects: 38
Study 15249280 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 2010
Study 11315833 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic care clinics (intervention)
Number of subjects: 8
Study 11315833 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 8
Study 9352174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary irradiation
Number of subjects: 0
Study 9352174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8203982 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose GH (0.1 mg/kg)
Number of subjects: 12
Study 8203982 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose GH (0.2 mg/kg)
Number of subjects: 12
Study 8203982 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study 8203982 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled analysis of GH-treated patients
Number of subjects: 12
Study 3316514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide monotherapy
Number of subjects: 1032
Study 3316514 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF (Cyclophosphamide, Methotrexate, and 5‐fluorouracil)
Number of subjects: 1032
Study 3316514 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 1032
Study 31480897 — intervention group
Group type: EXPERIMENTAL
Intervention: COP movement tracking training in dynamic mode (unstable)
Number of subjects: 26
Study 31480897 — intervention group
Group type: COMPARATOR
Intervention: COP movement tracking training in static mode (stable)
Number of subjects: 26
Study 29172862 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia
Number of subjects: 70
Study 29172862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischiorectal Block
Number of subjects: 70
Study 28219088 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Bundle (SB) ACL reconstruction
Number of subjects: 60
Study 28219088 — intervention group
Group type: COMPARATOR
Intervention: Double-Bundle (DB) ACL reconstruction
Number of subjects: 60
Study 26221061 — intervention group
Group type: EXPERIMENTAL
Intervention: Optive (compatible solutes) eye drops
Number of subjects: 24
Study 26221061 — intervention group
Group type: COMPARATOR
Intervention: Hylogel (sodium hyaluronate 0.2%)
Number of subjects: 24
Study 23024098 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% dextrose (25 D)
Number of subjects: 210
Study 23024098 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressed breast milk (EBM)
Number of subjects: 210
Study 23024098 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (SW)
Number of subjects: 210
Study 20499394 — intervention group
Group type: EXPERIMENTAL
Intervention: Urn randomization
Number of subjects: 30
Study 20499394 — intervention group
Group type: COMPARATOR
Intervention: Simple randomization
Number of subjects: 30
Study 18200020 — intervention group
Group type: EXPERIMENTAL
Intervention: sPLA(2) activity in infants with documented sepsis
Number of subjects: 156
Study 18200020 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP concentration in infants with documented sepsis
Number of subjects: 156
Study 18200020 — intervention group
Group type: EXPERIMENTAL
Intervention: I/T ratio in infants with documented sepsis
Number of subjects: 156
Study 18200020 — intervention group
Group type: EXPERIMENTAL
Intervention: sPLA(2) activity in infants with respiratory distress syndrome (RDS)
Number of subjects: 156
Study 18200020 — intervention group
Group type: EXPERIMENTAL
Intervention: sPLA(2) compared to CRP
Number of subjects: 156
Study 18200020 — intervention group
Group type: EXPERIMENTAL
Intervention: sPLA(2) compared to I/T ratio
Number of subjects: 156
Study 15850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved side flexor strength at 5 weeks (p = 0.029)
Number of subjects: 102
Study 15850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved side flexor strength at 10 weeks (p = 0.013)
Number of subjects: 102
Study 15850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved side flexor strength at 4 months (p = 0.021)
Number of subjects: 102
Study 15850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexor/extensor strength ratio in men on involved side (p = 0.119)
Number of subjects: 102
Study 15850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength values normalized to uninvolved knee
Number of subjects: 102
Study 12612277 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone (400 micro g/d for 4 weeks, then 200 micro g/d for 24 weeks)
Number of subjects: 53
Study 12612277 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone (200 micro g/d for 24 weeks)
Number of subjects: 53
Study 12612277 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 53
Study 10561358 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan and cytarabine
Number of subjects: 86
Study 8627081 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody levels to pertussis toxin (PT) measured by ELISA
Number of subjects: 585
Study 8627081 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody levels to filamentous hemagglutinin (FHA) measured by ELISA
Number of subjects: 585
Study 8627081 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody levels to PT and FHA
Number of subjects: 585
Study 1750720 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniphyl tablets taken with food
Number of subjects: 22
Study 1750720 — intervention group
Group type: COMPARATOR
Intervention: Uniphyl tablets taken under fasting conditions
Number of subjects: 22
Study 7149102 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxamniquine (20 mg/kg a day for 3 days)
Number of subjects: 116
Study 7149102 — intervention group
Group type: COMPARATOR
Intervention: Niridazole (15 mg/kg a day for 8 days)
Number of subjects: 116
Study 30798410 — intervention group
Group type: EXPERIMENTAL
Intervention: High sleep quality (SQI ≥ 80)
Number of subjects: 100
Study 30798410 — intervention group
Group type: COMPARATOR
Intervention: Low sleep quality (SQI < 60)
Number of subjects: 100
Study 30798410 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC sleep quality (SQI)
Number of subjects: 100
Study 28673802 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular Activity Breaks (RAB)
Number of subjects: 36
Study 28673802 — intervention group
Group type: EXPERIMENTAL
Intervention: RAB + Continuous Walking (RAB + PAD1)
Number of subjects: 36
Study 28673802 — intervention group
Group type: EXPERIMENTAL
Intervention: RAB + PAD1
Number of subjects: 36
Study 28673802 — intervention group
Group type: EXPERIMENTAL
Intervention: RAB
Number of subjects: 36
Study 28673802 — intervention group
Group type: COMPARATOR
Intervention: SIT (Control)
Number of subjects: 36
Study 26012289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (parents record daily symptom scores and receive short messages from doctors)
Number of subjects: 100
Study 26012289 — intervention group
Group type: COMPARATOR
Intervention: Control group (parents do not record daily symptom scores and do not receive short messages)
Number of subjects: 100
Study 23371291 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral for genetic counseling
Number of subjects: 2524
Study 23371291 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic testing
Number of subjects: 2524
Study 23371291 — intervention group
Group type: EXPERIMENTAL
Intervention: Caucasian women with higher income and education levels
Number of subjects: 2524
Study 23371291 — intervention group
Group type: EXPERIMENTAL
Intervention: BRCA testing
Number of subjects: 2524
Study 21323732 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon A contact lenses (high Dk)
Number of subjects: 20
Study 21323732 — intervention group
Group type: EXPERIMENTAL
Intervention: Etafilcon A contact lenses (low Dk)
Number of subjects: 20
Study 21323732 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbscan measurements with 0.92 acoustic factor
Number of subjects: 20
Study 19955069 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 38